Takeda

Takeda's reported carbon emissions

Takeda, a pharmaceutical preparation manufacturing company headquartered in Japan, reported approximately 3.096 billion kg CO2e in total emissions for 2024. This figure encompasses Scope 1, 2, and 3 emissions, with Scope 3 emissions accounting for the largest portion at approximately 2.795 billion kg CO2e, primarily driven by purchased goods and services. In 2023, Takeda's total emissions were approximately 4.265 billion kg CO2e, with Scope 3 contributing around 3.953 billion kg CO2e. The previous year, 2022, saw total emissions of approximately 5.612 billion kg CO2e, with Scope 3 emissions at approximately 2.995 billion kg CO2e. Takeda has set ambitious climate commitments, including achieving net-zero greenhouse gas emissions across its entire value chain by 2040. For its operations (Scopes 1 and 2), Takeda aims for net-zero emissions before 2035, and has a near-term target to achieve net-zero emissions across its operations by 2030. Additionally, Takeda has committed to reducing absolute Scope 1 and 2 GHG emissions by 65% by FY2030 from a FY2016 base year and by 90% by FY2035. Takeda also aims to reduce absolute Scope 3 GHG emissions by 25% by FY2030 from a FY2022 base year, and by 90% by FY2040. Science-based targets for Scope 1 and 2 emissions include a 40% reduction by FY2025 from a FY2016 base year, and a 100% reduction by FY2040. Furthermore, Takeda aims to have 67% of its suppliers by emissions, covering purchased goods and services, capital goods, and upstream transportation and distribution, achieve science-based targets by 2024.